All Stories

  1. Life Expectancy, Loss of Life Expectancy, and Lifetime Costs in Bipolar Disorder: A Nationwide Population‐Based Study
  2. Navigating the Digital Maze: A Review of AI Bias, Social Media, and Mental Health in Generation Z
  3. Omega-3 Fatty Acids and Neuroinflammation in Depression: Targeting Damage-Associated Molecular Patterns and Neural Biomarkers
  4. The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
  5. Omega-3 polyunsaturated fatty acids in the prevention of relapse in patients with stable bipolar disorder: A 6-month pilot randomized controlled trial
  6. Roles of Omega-3 Polyunsaturated Fatty Acids in Managing Cognitive Impairment in Chronic Obstructive Pulmonary Disease: A Review
  7. The Now and Future of ChatGPT and GPT in Psychiatry
  8. Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients
  9. Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients
  10. Psychological Outcomes and Quality of Life of Fibromyalgia Patients with Vitamin D Supplementation—A Meta-Analysis
  11. Omega-3 Polyunsaturated Fatty Acids in Managing Comorbid Mood Disorders in Chronic Obstructive Pulmonary Disease (COPD): A Review
  12. The Clinical Observation of Inflammation Theory for Depression: The Initiative of the Formosa Long COVID Multicenter Study (FOCuS)
  13. Identification of Genetic Variations in the NAD-Related Pathways for Patients with Major Depressive Disorder: A Case-Control Study in Taiwan
  14. Personalised medicine in child and Adolescent Psychiatry: Focus on omega-3 polyunsaturated fatty acids and ADHD
  15. Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis
  16. Efficacy and acceptability of different interventions for acrophobia: A network meta-analysis of randomised controlled trials
  17. Challenges and opportunities for early career child mental health professionals during the COVID19 pandemic
  18. Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents
  19. Plasma estradiol levels and antidepressant effects of omega-3 fatty acids in pregnant women
  20. Somatic pain associated with initiation of interferon-alpha (IFN-α) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study
  21. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels
  22. Major depressive episodes during pregnancy and after childbirth: A prospective longitudinal study in Taiwan
  23. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study
  24. Atypical major depressive episode as initial presentation of intracranial germinoma in a male adolescent
  25. Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection
  26. Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression
  27. Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial
  28. Serotonin-Norepinephrine Reuptake Inhibitor–Associated Mixed Episode in an Adolescent With Schizoaffective Disorder
  29. View on DSM from Taiwan: transition from IV to 5
  30. Maternal parenting styles and mother–child relationship among adolescents with and without persistent attention-deficit/hyperactivity disorder
  31. Serotonin-Norepinephrine Reuptake Inhibitor Treatment for Tinnitus and Depression
  32. Introducing the concept of modern depression in Japan; an international case vignette survey
  33. Early detection and management of atypical neuroleptic malignant syndrome secondary to aripiprazole
  34. Does the ‘hikikomori’ syndrome of social withdrawal exist outside Japan? A preliminary international investigation
  35. Omega-3 Polyunsaturated Fatty Acids (PUFAs) as the "Mind-Body Interface" in Cardiovascular Diseases and Depression
  36. A case of venlafaxine-induced bruxism alleviated by duloxetine substitution
  37. A Case of Milnacipran-Related Sweating Alleviated by Duloxetine Substitution
  38. Reliability and validity of three Chinese-version tasks of Mayer-Salovey-Caruso Emotional Intelligence Test
  39. Paliperidone overdose in a patient with schizophrenia
  40. Emotional management and 5-HT2A receptor gene variance in patients with schizophrenia
  41. Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Cardiovascular Diseases (CVDs) and Depression: The Missing Link?
  42. Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) treatment for Isaacs syndrome with depression